Microvision Wins Second DARPA Contract.BOTHELL, Wash., May 24 /PRNewswire/ -- Microvision, Inc. (Nasdaq: MVIS MVIS Microvision Inc (Redmond, Washington) , MVISW), developer of the heavily patented Virtual Retinal Display A virtual retinal display (VRD), also known as a retinal scan display (RSD), is a new display technology that draws a raster display (like a television) directly onto the retina of the eye. (TM) (VRD VRD Virtual Reference Desk
VRD Virtual Retinal Display
VRD Voirie et Réseaux Divers (French: External Works, or Roads & Utility Services)
VRD Vocational Rehabilitation Division (Oregon DHS) (TM)) technology today announced that it has received funding for a second Phase I contract from the Defense Advanced Research Projects Administration (DARPA DARPA: see Defense Advanced Research Projects Agency.
(Defense Advanced Research Projects Agency) The name given to the U.S. Advanced Research Projects Agency during the 1980s. It was later renamed back to ARPA. ). Microvision will design a revolutionary "Autoscope" which allows multiple viewers to see a stereoscopic stereoscopic /ster·eo·scop·ic/ (ster?e-o-skop´ik) having the effect of a stereoscope; giving objects a solid or three-dimensional appearance.
1. , 3-D virtual image without the need for a head-worn device or special viewing aids. Microvision will construct a proof-of-concept demonstrator, with the possibility of a second phase contract for further product development.
Work performed during Phase I will include the design of an Autoscope to meet the military's needs in various command-and-control applications. Additionally, the design has the potential to directly support an existing need in the medical community for high-performance, high-resolution, 3-D, off-the-head displays to service the growing requirements associated with minimally invasive and microsurgical procedures. Research analysts forecast that approximately 12 million endoscopic en·do·scope
An instrument for examining visually the interior of a bodily canal or a hollow organ such as the colon, bladder, or stomach.
en surgical procedures and explorations, including cardiovascular and arthroscopic procedures, will be conducted by the year 2000.
"As we continue to develop exciting head-worn applications for the VRD technology, we also see the need for high-fidelity binocular 3-D displays that require no viewing aids, unlike head-worn displays," said Dr. Thomas Lippert, Microvision Principal Scientist and Principal Investigator for the Autoscope Project. "But the highly complex nature of existing auto-stereoscopic display systems limits their success in applications where video image quality is of prime importance. For example, holograms are current forms of auto- stereoscopic displays which remain optically complex, expensive, static, and incompatible with electronic image sourcing in general. Other approaches suffer from optical complexity, difficult maintenance of multiple image alignment, and generally low image quality. We believe Microvision's Autoscope is the best approach to the development of an auto-stereoscopic display because it combines optical simplicity with the VRD technology's inherent benefits. The VRD technology features unmatched brightness and color gamut, high contrast and color resolution, and high bandwith analog line scanning for the greatest stereo image fidelity as well as pixilated pix·i·lat·ed or pix·il·lat·ed
1. Behaving as if mentally unbalanced; very eccentric.
2. Whimsical; prankish.
3. Slang Intoxicated; drunk. video signal compatibility. Our objective is to provide revolutionary displays that fully exploit human visual capabilities, while paying special attention to user-friendly design requirements. In this manner we can meaningfully improve user confidence and critical task performance."
"We are honored to have been selected by DARPA with our second contract this year," stated Rick Rutkowski, Microvision President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . "DARPA's overall mission is to develop imaginative, innovative, and high-risk research technologies offering a significant technological impact that will go well beyond the normal evolutionary developmental approaches, and to pursue these ideas from the demonstration of technical feasibility through the development of prototype systems. Their funding of our technology development is a strong validation of the product value we can deliver to multiple users in the military and commercial sectors."
Headquartered in Seattle, Microvision, Inc. (Nasdaq: MVIS, MVISW) is the developer of the patented Virtual Retinal Display(TM) (VRD(TM)) technology that uses a rapidly scanned beam of light to project images on the eye's retina, allowing the viewer to see large, full-motion images without the need for a conventional display screen. Microvision's objective is to be a leading provider of personal display products and imaging technology in a broad range of military, medical, industrial, professional and consumer applications. The company was founded in 1993. Additional information can be found at the company's website at http://www.mvis.com.
The information set forth in this release includes "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and is subject to the safe harbor created by those sections. Certain factors that realistically could cause results to differ materially from those projected in the company's forward-looking statements are set forth in the company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, as filed with the Securities and Exchange Commission.